Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Strides Pharma Science Limited
| Okres |
2023-03-31 |
2024-03-31 |
2025-03-31 |
2026-03-31 |
| Przychód (średnia) |
37,598.00 |
40,511.24 |
46,169.00 |
50,750.00 |
| Przychód Δ r/r |
0.00% |
7.75% |
13.97% |
9.92% |
| Przychód (min) |
36,705.14 |
39,989.06 |
46,051.04 |
50,180.80 |
| Przychód (max) |
37,895.76 |
41,033.42 |
46,286.96 |
51,319.20 |
| EBITDA (średnia) |
221.76 |
242.13 |
265.99 |
5,729.58 |
| EBIT (średnia) |
4,099.41 |
4,476.02 |
4,916.98 |
2,363.18 |
| EBIT % |
10.90% |
11.05% |
10.65% |
4.66% |
| Zysk netto (średni) |
503.15 |
-1,248.34 |
4,327.00 |
4,446.67 |
| Zysk netto % |
1.34% |
-3.08% |
9.37% |
8.76% |
| EPS (średnia) |
-5.47 |
-13.72 |
47.70 |
63.45 |
| Liczba analityków (Przychody) |
3 |
2 |
2 |
3 |
| Liczba analityków (EPS) |
0 |
2 |
2 |
2 |
| symbol |
STAR.NS |
STAR.NS |
STAR.NS |
STAR.NS |